ID   TRI72_HUMAN             Reviewed;         477 AA.
AC   Q6ZMU5; Q8N4X6; Q8NBD9;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   28-JUN-2023, entry version 158.
DE   RecName: Full=Tripartite motif-containing protein 72;
DE   AltName: Full=Mitsugumin-53;
DE            Short=Mg53;
GN   Name=TRIM72 {ECO:0000312|HGNC:HGNC:32671}; Synonyms=MG53;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAD18630.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum {ECO:0000312|EMBL:BAC03506.1}, and Thymus
RC   {ECO:0000312|EMBL:BAD18630.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH33211.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Muscle {ECO:0000312|EMBL:AAH33211.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   S-NITROSYLATION AT CYS-144, AND MUTAGENESIS OF CYS-144.
RX   PubMed=24487118; DOI=10.1016/j.yjmcc.2014.01.010;
RA   Kohr M.J., Evangelista A.M., Ferlito M., Steenbergen C., Murphy E.;
RT   "S-nitrosylation of TRIM72 at cysteine 144 is critical for protection
RT   against oxidation-induced protein degradation and cell death.";
RL   J. Mol. Cell. Cardiol. 69:67-74(2014).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 278-470.
RX   PubMed=19967786; DOI=10.1002/prot.22647;
RA   Park E.Y., Kwon O.B., Jeong B.C., Yi J.S., Lee C.S., Ko Y.G., Song H.K.;
RT   "Crystal structure of PRY-SPRY domain of human TRIM72.";
RL   Proteins 78:790-795(2010).
CC   -!- FUNCTION: Muscle-specific protein that plays a central role in cell
CC       membrane repair by nucleating the assembly of the repair machinery at
CC       injury sites. Specifically binds phosphatidylserine. Acts as a sensor
CC       of oxidation: upon membrane damage, entry of extracellular oxidative
CC       environment results in disulfide bond formation and homooligomerization
CC       at the injury site. This oligomerization acts as a nucleation site for
CC       recruitment of TRIM72-containing vesicles to the injury site, leading
CC       to membrane patch formation. Probably acts upstream of the Ca(2+)-
CC       dependent membrane resealing process. Required for transport of DYSF to
CC       sites of cell injury during repair patch formation. Regulates membrane
CC       budding and exocytosis. May be involved in the regulation of the
CC       mobility of KCNB1-containing endocytic vesicles (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homooligomer; disulfide-linked. Interacts with DYSF and CAV3
CC       (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q6ZMU5; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-2341648, EBI-11096309;
CC       Q6ZMU5; Q8TAB5: C1orf216; NbExp=3; IntAct=EBI-2341648, EBI-747505;
CC       Q6ZMU5; Q13503: MED21; NbExp=3; IntAct=EBI-2341648, EBI-394678;
CC       Q6ZMU5; Q08AG7: MZT1; NbExp=3; IntAct=EBI-2341648, EBI-2637198;
CC       Q6ZMU5; Q13287: NMI; NbExp=3; IntAct=EBI-2341648, EBI-372942;
CC       Q6ZMU5; Q08209-2: PPP3CA; NbExp=3; IntAct=EBI-2341648, EBI-11959013;
CC       Q6ZMU5; Q96GM5: SMARCD1; NbExp=3; IntAct=EBI-2341648, EBI-358489;
CC       Q6ZMU5; Q99081: TCF12; NbExp=3; IntAct=EBI-2341648, EBI-722877;
CC       Q6ZMU5; Q99081-3: TCF12; NbExp=3; IntAct=EBI-2341648, EBI-11952764;
CC       Q6ZMU5; Q6ZMU5: TRIM72; NbExp=3; IntAct=EBI-2341648, EBI-2341648;
CC       Q6ZMU5; Q8N720: ZNF655; NbExp=3; IntAct=EBI-2341648, EBI-625509;
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma {ECO:0000250}.
CC       Cytoplasmic vesicle membrane {ECO:0000250}. Note=Tethered to plasma
CC       membrane and cytoplasmic vesicles via its interaction with
CC       phosphatidylserine. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:14702039};
CC         IsoId=Q6ZMU5-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:15489334};
CC         IsoId=Q6ZMU5-2; Sequence=VSP_052318;
CC   -!- PTM: Disulfide bond formation at Cys-242 occurs in case of membrane
CC       damage that cause the entry of the oxidized milieu of the extracellular
CC       space, resulting in homooligomerization. {ECO:0000250}.
CC   -!- PTM: S-nitrosylation at Cys-144 stabilizes TRIM72 and protects against
CC       oxidation-induced protein degradation and cell death.
CC       {ECO:0000269|PubMed:24487118}.
CC   -!- SIMILARITY: Belongs to the TRIM/RBCC family. {ECO:0000255}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03506.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK090695; BAC03506.1; ALT_INIT; mRNA.
DR   EMBL; AK131485; BAD18630.1; -; mRNA.
DR   EMBL; AC009088; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033211; AAH33211.1; -; mRNA.
DR   CCDS; CCDS32437.1; -. [Q6ZMU5-1]
DR   RefSeq; NP_001008275.2; NM_001008274.3. [Q6ZMU5-1]
DR   PDB; 3KB5; X-ray; 1.50 A; A=278-470.
DR   PDB; 7XT2; X-ray; 3.00 A; A/B=1-477.
DR   PDB; 7Y4S; EM; 3.50 A; A/B=1-477.
DR   PDBsum; 3KB5; -.
DR   PDBsum; 7XT2; -.
DR   PDBsum; 7Y4S; -.
DR   AlphaFoldDB; Q6ZMU5; -.
DR   SMR; Q6ZMU5; -.
DR   BioGRID; 138920; 50.
DR   IntAct; Q6ZMU5; 13.
DR   MINT; Q6ZMU5; -.
DR   STRING; 9606.ENSP00000312675; -.
DR   TCDB; 1.F.1.2.1; the synaptosomal vesicle fusion pore (svf-pore) family.
DR   iPTMnet; Q6ZMU5; -.
DR   PhosphoSitePlus; Q6ZMU5; -.
DR   BioMuta; TRIM72; -.
DR   DMDM; 126253816; -.
DR   EPD; Q6ZMU5; -.
DR   jPOST; Q6ZMU5; -.
DR   MassIVE; Q6ZMU5; -.
DR   MaxQB; Q6ZMU5; -.
DR   PaxDb; Q6ZMU5; -.
DR   PeptideAtlas; Q6ZMU5; -.
DR   ProteomicsDB; 67918; -. [Q6ZMU5-1]
DR   ProteomicsDB; 67919; -. [Q6ZMU5-2]
DR   Antibodypedia; 14026; 223 antibodies from 31 providers.
DR   DNASU; 493829; -.
DR   Ensembl; ENST00000322122.8; ENSP00000312675.3; ENSG00000177238.14. [Q6ZMU5-1]
DR   Ensembl; ENST00000613872.1; ENSP00000481813.1; ENSG00000177238.14. [Q6ZMU5-2]
DR   GeneID; 493829; -.
DR   KEGG; hsa:493829; -.
DR   MANE-Select; ENST00000322122.8; ENSP00000312675.3; NM_001008274.4; NP_001008275.2.
DR   UCSC; uc002ebn.3; human. [Q6ZMU5-1]
DR   AGR; HGNC:32671; -.
DR   CTD; 493829; -.
DR   DisGeNET; 493829; -.
DR   GeneCards; TRIM72; -.
DR   HGNC; HGNC:32671; TRIM72.
DR   HPA; ENSG00000177238; Group enriched (skeletal muscle, tongue).
DR   MIM; 613288; gene.
DR   neXtProt; NX_Q6ZMU5; -.
DR   OpenTargets; ENSG00000177238; -.
DR   PharmGKB; PA144596247; -.
DR   VEuPathDB; HostDB:ENSG00000177238; -.
DR   eggNOG; KOG2177; Eukaryota.
DR   GeneTree; ENSGT00940000161791; -.
DR   HOGENOM; CLU_013137_0_3_1; -.
DR   InParanoid; Q6ZMU5; -.
DR   OMA; ECVEHKQ; -.
DR   OrthoDB; 3453019at2759; -.
DR   PhylomeDB; Q6ZMU5; -.
DR   TreeFam; TF342569; -.
DR   PathwayCommons; Q6ZMU5; -.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   SignaLink; Q6ZMU5; -.
DR   SIGNOR; Q6ZMU5; -.
DR   BioGRID-ORCS; 493829; 26 hits in 1183 CRISPR screens.
DR   ChiTaRS; TRIM72; human.
DR   EvolutionaryTrace; Q6ZMU5; -.
DR   GenomeRNAi; 493829; -.
DR   Pharos; Q6ZMU5; Tbio.
DR   PRO; PR:Q6ZMU5; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q6ZMU5; protein.
DR   Bgee; ENSG00000177238; Expressed in hindlimb stylopod muscle and 110 other tissues.
DR   Genevisible; Q6ZMU5; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0001786; F:phosphatidylserine binding; ISS:UniProtKB.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0007517; P:muscle organ development; ISS:UniProtKB.
DR   GO; GO:0003012; P:muscle system process; ISS:UniProtKB.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; IEA:Ensembl.
DR   GO; GO:0001778; P:plasma membrane repair; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   CDD; cd16612; RING-HC_TRIM72_C-IV; 1.
DR   CDD; cd13742; SPRY_PRY_TRIM72; 1.
DR   Gene3D; 2.60.120.920; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR043136; B30.2/SPRY_sf.
DR   InterPro; IPR003879; Butyrophylin_SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR006574; PRY.
DR   InterPro; IPR003877; SPRY_dom.
DR   InterPro; IPR027370; Znf-RING_euk.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR24103; E3 UBIQUITIN-PROTEIN LIGASE TRIM; 1.
DR   PANTHER; PTHR24103:SF11; TRIPARTITE MOTIF-CONTAINING PROTEIN 72; 1.
DR   Pfam; PF13765; PRY; 1.
DR   Pfam; PF00622; SPRY; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   PRINTS; PR01407; BUTYPHLNCDUF.
DR   SMART; SM00336; BBOX; 1.
DR   SMART; SM00589; PRY; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00449; SPRY; 1.
DR   SUPFAM; SSF57845; B-box zinc-binding domain; 1.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50188; B302_SPRY; 1.
DR   PROSITE; PS50119; ZF_BBOX; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Coiled coil;
KW   Cytoplasmic vesicle; Disulfide bond; Exocytosis; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; S-nitrosylation; Transport; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..477
FT                   /note="Tripartite motif-containing protein 72"
FT                   /id="PRO_0000278130"
FT   DOMAIN          271..475
FT                   /note="B30.2/SPRY"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00548"
FT   ZN_FING         14..57
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         81..122
FT                   /note="B box-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   COILED          135..169
FT                   /evidence="ECO:0000255"
FT   BINDING         86
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         89
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         108
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         114
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   MOD_RES         144
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000269|PubMed:24487118"
FT   MOD_RES         255
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A0JPQ4"
FT   DISULFID        242
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         270..477
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_052318"
FT   MUTAGEN         144
FT                   /note="C->S: No decrease in level upon treatment with
FT                   hydrogen peroxide."
FT                   /evidence="ECO:0000269|PubMed:24487118"
FT   CONFLICT        192
FT                   /note="R -> C (in Ref. 1; BAD18630)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        315
FT                   /note="E -> G (in Ref. 1; BAC03506)"
FT                   /evidence="ECO:0000305"
FT   HELIX           279..284
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   TURN            295..297
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          302..305
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   TURN            306..309
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          310..313
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          329..331
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          333..337
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          342..350
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          355..363
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          369..371
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   HELIX           376..378
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          380..386
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   TURN            387..389
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          390..393
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          396..399
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          411..418
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   TURN            419..422
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          423..428
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          436..441
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          449..454
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   TURN            459..463
FT                   /evidence="ECO:0007829|PDB:3KB5"
FT   STRAND          467..469
FT                   /evidence="ECO:0007829|PDB:3KB5"
SQ   SEQUENCE   477 AA;  52731 MW;  2B4EE9A00318151F CRC64;
     MSAAPGLLHQ ELSCPLCLQL FDAPVTAECG HSFCRACLGR VAGEPAADGT VLCPCCQAPT
     RPQALSTNLQ LARLVEGLAQ VPQGHCEEHL DPLSIYCEQD RALVCGVCAS LGSHRGHRLL
     PAAEAHARLK TQLPQQKLQL QEACMRKEKS VAVLEHQLVE VEETVRQFRG AVGEQLGKMR
     VFLAALEGSL DREAERVRGE AGVALRRELG SLNSYLEQLR QMEKVLEEVA DKPQTEFLMK
     YCLVTSRLQK ILAESPPPAR LDIQLPIISD DFKFQVWRKM FRALMPALEE LTFDPSSAHP
     SLVVSSSGRR VECSEQKAPP AGEDPRQFDK AVAVVAHQQL SEGEHYWEVD VGDKPRWALG
     VIAAEAPRRG RLHAVPSQGL WLLGLREGKI LEAHVEAKEP RALRSPERRP TRIGLYLSFG
     DGVLSFYDAS DADALVPLFA FHERLPRPVY PFFDVCWHDK GKNAQPLLLV GPEGAEA
//
